MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-12-0002276
Finebiotics Pharma Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹26.36 Cr
▼ 21% YoY
Net loss · FY 2025
₹2.27 Cr
Net margin -8.6%
EBITDA · FY 2025
-₹1.56 Cr
EBITDA margin -5.9%
Authorised capital
₹11.5 Cr
Registered with MCA
Paid-up capital
₹11.5 Cr
Issued & subscribed
Open charges
₹3.53 Cr
Satisfied ₹10.82 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
53
Provident fund records
About Finebiotics Pharma Limited
Data last updated:
Finebiotics Pharma Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 August 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2004PLC044581. Its GSTIN is 05AADCP6328G1ZJ (Uttarakhand).
The company has an authorised share capital of ₹11.5 Cr and a paid-up capital of ₹11.5 Cr. It was formerly known as Finebiotics Pharma Private Limited and Pharland Health Care Private Limited. It is led by directors including Vedprakash Amarchand Agarwal (Whole-Time Director) and Vivek Rajgarhia.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 1401 Mondeal Heights Nr. Wide Angle Cinema S.G. Highway, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.36 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net loss of ₹2.27 Cr (net margin -8.6%) and EBITDA of -₹1.56 Cr (EBITDA margin -5.9%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 2% over five years.
The company has about 53 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Fine Biotics. As per MCA filings, the company has open charges of ₹3.53 Cr and satisfied charges of ₹10.82 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
Finebiotics Pharma Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-12-0002276). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website finebiotics.com.
Company details
CIN U24231GJ2004PLC044581
Registration Number 044581
Incorporation Date 10 August 2004
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-12-0002276
Name history
Finebiotics Pharma has undergone 2 name changes throughout its history. The company was previously known as Finebiotics Pharma Private Limited, and Pharland Health Care Private Limited. The current legal name is Finebiotics Pharma Limited.
| Company Name | Status |
|---|---|
| Finebiotics Pharma Limited | Current |
| Finebiotics Pharma Private Limited | Previous |
| Pharland Health Care Private Limited | Previous |
CIN history
Finebiotics Pharma has one previous CIN (Corporate Identification Number): U24231GJ2004PTC044581. The current CIN is U24231GJ2004PLC044581, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231GJ2004PLC044581 | Current |
| U24231GJ2004PTC044581 | Previous |
Key People
Vedprakash Amarchand Agarwal Whole-Time Director Vivek Rajgarhia Director Niraj Kumar Harodia Director Recognitions & Rankings of Finebiotics Pharma
Contact details
Finebiotics Pharma Limited's registered office is in Ahmedabad, Gujarat. Its website is finebiotics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressA – 1401 Mondeal Heights Nr. Wide Angle Cinema S.G. Highway, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Finebiotics Pharma Limited, buy the company report.
Comprehensive company report
Finebiotics Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Finebiotics Pharma operates one associated brand: Fine Biotics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures high-quality pharmaceutical products including Beta-Lactam dry powder injections. | finebiotics.com |
Business activity
The main business activities of Finebiotics Pharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Finebiotics Pharma Limited, buy the company report.
Financials of Finebiotics Pharma Limited
FY 2025 filings availableFinebiotics Pharma Limited reported revenue of ₹26.36 Cr (down 21% YoY) for FY 2025.
Revenue · FY 2025
₹26.36 Cr ▼ 21%
Net loss · FY 2025
₹2.27 Cr margin -8.6%
EBITDA · FY 2025
-₹1.56 Cr margin -5.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 21%
3 years · compounded
▼ 6%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 704%
3 years · compounded
▼ 63%
5 years · compounded
▼ 32%
Revenue fell 21% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 704% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.56 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.27 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.9% | ||||
| Net Profit Margin | -8.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Finebiotics Pharma Limited, buy the company report.
Board of directors of Finebiotics Pharma Limited
Finebiotics Pharma has 7 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vivek Rajgarhia | Director | 16 Aug 2012 | 14 Years 2 Months | Current |
| Niraj Kumar Harodia Also directs: Finecure Pharmaceuticals Limited, JMNR & Associates LLP, The Grob Tea Co Ltd and 1 more | Director | 28 Jan 2025 | 1 Years 8 Months | Current |
| Mayank Rajeev Kedia Also directs: Unotex Pharma LLP | Director | 01 Jul 2020 | 6 Years 3 Months | Current |
| Vedprakash Amarchand Agarwal Also directs: Techografix Printpack Private Limited | Whole-Time Director | 16 Aug 2012 | 14 Years 2 Months | Current |
| Parshva Shashikant Jhaveri | Director | 17 Dec 2020 | 5 Years 10 Months | Current |
| Pradipbhai Ratilal Shah Also directs: Fair Rim Healthcare LLP | Director | 16 Aug 2012 | 14 Years 2 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Finebiotics Pharma Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sudarshan Pharmaceuticals Pvt Ltd | ₹26.53 Cr (FY 2025) | 1.0% | Indore, Madhya Pradesh, India | |||
| M R Health Care Private Limited | ₹26.48 Cr (FY 2025) | 3.0% | Uttarakhand, India | |||
| Greensignal Bio Pharma Private Limited | ₹26.42 Cr (FY 2025) | 5.0% | Chennai, Tamil Nadu, India | |||
| Symbiotic Therapeutics Private Limited | ₹26.4 Cr (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Soft Medicaps Limited | ₹26.38 Cr (FY 2025) | 87.0% | Indore, Madhya Pradesh, India | |||
| Finebiotics Pharma Limitedthis company | ₹26.36 Cr (FY 2025) | -₹2.27 Cr | -8.6% | -21.0% | 53 | Ahmedabad, Gujarat, India |
| Zenzi Pharmaceutical Industries Private Limited | ₹26.29 Cr (FY 2025) | -34.0% | Murbad, Maharashtra, India | |||
| Indi Pharma Private Limited | ₹26.28 Cr (FY 2024) | -6.0% | Goa, India |
To see the full peer comparison of Finebiotics Pharma Limited, buy the company report.
Auditor
Finebiotics Pharma Limited is audited by SHAH & IYER for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHAH & IYER | FY 2024 | 124443W |
Shareholding
The shareholding of Finebiotics Pharma Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Finebiotics Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹3.53 Cr
Satisfied charges
₹10.82 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Sep 2023 | 100794506 | Others | ₹3 Cr | Open | |
| 15 Apr 2021 | 100437302 | Others | ₹13.88 Lakh | Open | |
| 15 Apr 2021 | 100437301 | Others | ₹23.15 Lakh | Open | |
| 29 Jul 2020 | 100357452 | Others | ₹4.32 Lakh | Open | |
| 27 Jun 2019 | 100272250 | Others | ₹4.5 Lakh | Open |
To see the full charge records of Finebiotics Pharma Limited, buy the company report.
Total charge records: 16 View all charges
Legal cases
Finebiotics Pharma Limited has 1 court case on record: 1 filed by Finebiotics Pharma. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed by the company against an individual | Disposed |
To see the full case history of Finebiotics Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Finebiotics Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Finebiotics Pharma Limited has a workforce of 53 employees on its EPFO records as of Mar 07, 2025, across 1 active EPFO establishment.
Employee count
53
Active EPFO establishments
1
Employee growth
15.22%
GST
Finebiotics Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AADCP6328G1ZJ | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Finebiotics Pharma Limited, buy the company report.
Recent activity
Finebiotics Pharma Limited has 21 board changes on record since 2008: 7 appointments and 14 cessations. The latest: Niraj Kumar Harodia was appointed as Director on 28 Jan 2025.
AGM
Finebiotics Pharma Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Finebiotics Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Niraj Kumar Harodia was appointed as Director.
Ceased
Parshva Shashikant Jhaveri ceased to be Director.
Charges
A charge with Others of Rs. 3.00 Cr registered on 20 Sep 2023 with Charge ID 100794506 was modified on 10 Oct 2023.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100794506 was registered on 20 Sep 2023.
Ceased
Mayank Rajeev Kedia ceased to be Whole-Time Director.
Charges
A charge registered on 21 Mar 2020 via Charge ID 100342899 with Others was fully satisfied on 16 Jul 2021.
Charges
A charge registered on 22 Dec 2020 via Charge ID 100403512 with Others was fully satisfied on 25 Jun 2021.
Charges
A charge with Others amounted to Rs. 0.14 Cr with Charge ID 100437302 was registered on 15 Apr 2021.
Charges
A charge with Others amounted to Rs. 0.23 Cr with Charge ID 100437301 was registered on 15 Apr 2021.
Charges
A charge with Others amounted to Rs. 0.17 Cr with Charge ID 100403512 was registered on 22 Dec 2020.
41 earlier events are in the company report.
Frequently asked questions
Finebiotics Pharma is an active public limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 August 2004 (22+ years old) and is registered under CIN U24231GJ2004PLC044581.
Finebiotics Pharma has 7 current directors:
- Vedprakash Amarchand Agarwal - Whole-Time Director
- Vivek Rajgarhia - Director
- Niraj Kumar Harodia - Director
- Mayank Rajeev Kedia - Director
- Parshva Shashikant Jhaveri - Director
- Pradipbhai Ratilal Shah - Director
- Mukesh Tarachand Agarwal - Director
The latest financial statements of Finebiotics Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Finebiotics Pharma is 05AADCP6328G1ZJ, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Finebiotics Pharma is U24231GJ2004PLC044581. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Finebiotics Pharma has 1 court case on record: 1 filed by the company.
Finebiotics Pharma was incorporated on 10 August 2004, making it 22+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Finebiotics Pharma by revenue are Sudarshan Pharmaceuticals Pvt Ltd, M R Health Care Private Limited, Greensignal Bio Pharma Private Limited, Symbiotic Therapeutics Private Limited, Soft Medicaps Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Niraj Kumar Harodia was appointed as Director on 28 Jan 2025. Parshva Shashikant Jhaveri ceased to be Director on 01 Nov 2024. Mayank Rajeev Kedia ceased to be Whole-Time Director on 03 Sep 2022. Finebiotics Pharma has 21 board changes on record in total.
Yes, Finebiotics Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-UK-12-0002276).
Finebiotics Pharma can be reached through the website finebiotics.com. Its registered office is in Ahmedabad, Gujarat, India.